Mark van Goor, theme Renal disorders, received the Radboudumc Master Prize for his MSc thesis entitled “High-resolution structure of the renal calcium channel TRPV5 revealed with cryo-EM”, which was based on his internship at the lab of Prof. Yifan Cheng, University of California San Francisco (USA).During this internship, Mark was involved in resolving the 3D structure of TRPV5 by cryo-electron microscopy. The Master Prize committee praised his work based on outstanding performance, critical evaluation and a well-structured report. Moreover, it resulted in a recent publication in Proceedings of the National Academy of Sciences, where Mark is co-author. During the award ceremony, Mark gave an engaging presentation explaining his work in layman’s terms.
He is now invited to attend the Opening of Academic Year on 2 September, where he will receive the Radboud University prize as best Radboudumc Msc thesis of the study year 2017-2018.
Mark is currently pursuing his interest in structural biology within his PhD research project at the department of Physiology, where he aims to unravel the molecular building blocks of renal sodium channels in an effort to structurally characterize diuretic-binding and diuretic activity modulation.
Related news items
Terrestrial bacteria can grow on nutrients from space26 May 2020
Researchers from the Radboudumc describe in an article in Astrobiology that bacteria can survive on an 'extraterrestrial diet', which affected their pathogenic potential.read more
Evaluation of an AI system for detection of COVID-19 on Chest X-Ray images22 May 2020
In the journal Radiology researchers from Radboudumc, Bernhoven Hospital and Jeroen Bosch Hospital described how an artificial intelligence system (CAD4COVID-XRay) can identify characteristics of COVID-19 on chest x-rays with performance comparable to six independent radiologists.read more
First clinical trial with genetically modified malaria vaccine completed22 May 2020
In an innovative study, Radboudumc and LUMC jointly tested a candidate vaccine based on a genetically weakened malaria parasite. The results of this clinical trial, published in Science Translational Medicine, show that the vaccine is safe and elicits a defense response against a malaria infection.read more
New step in the development of a vaccine against malaria22 May 2020
A new vaccine based on rodent malaria parasites achieved a 95% reduction in infection of the liver in humans. An international consortium publishes the results in Science Translational Medicine.read more